3D Medicines Inc. (HKG:1244)
Hong Kong · Delayed Price · Currency is HKD
3.750
+0.140 (3.88%)
Apr 17, 2026, 4:08 PM HKT
Revenue by Segment
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
|---|
Biopharmaceutical Research and Development | 445.65M | 634.95M | 567.39M | 60.26M | |
Biopharmaceutical Research and Development Growth | -29.81% | 11.91% | 841.57% | - | |
| 445.65M | 634.95M | 567.39M | 60.26M | |
| -29.81% | 11.91% | 841.57% | - | |
Revenue by Geography
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
|---|
| 445.65M | 634.95M | 567.39M | 60.26M | |
| -29.81% | 11.91% | 841.57% | - | |
| 445.65M | 634.95M | 567.39M | 60.26M | |
| -29.81% | 11.91% | 841.57% | - | |
Source: S&P Global Market Intelligence.
